Procter & Gamble CFO Andre Schulten sold 30,677 shares of the company’s common stock on November 5, 2026, for a total of $5.18 million. The shares were sold at a price of $169 each. At the same time, Schulten exercised stock options to acquire an equal number of shares, purchasing them at $78.52 per share, totaling $2.41 million.
Following these transactions, Schulten now directly holds 65,618 shares of Procter & Gamble common stock, with an additional 7,604 shares held indirectly through a retirement plan trustee.
In other news, Procter & Gamble has completed two major notes offerings. The company announced a €3.25 billion offering in senior notes, divided into four tranches with varying maturity dates and interest rates. Additionally, Procter & Gamble closed a $4 billion notes offering, structured across multiple maturities.
Analysts have adjusted their outlooks on the company. Piper Sandler raised its price target to $167, citing strong organic top-line momentum. TD Cowen increased its price target to $166, noting the company’s robust first-quarter performance. Morgan Stanley also raised its price target to $185, highlighting the company’s 6% profit and earnings per share upside, alongside a 4.0% organic sales growth that surpassed market expectations.